Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cocrystal Pharma Inc. COCP

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

COCP ....... Early a.m runner on NR

Now in PB mode.......$1.34 Look for support sub $1.30.....stops save portfolios Cheers !  rate and reply

COCP up in pre-market....on watch

Seems like ever since Feb 2020.....it pops on volume evry few months. Here we go again. ps: I don't chase  Cheers !  rate and reply

Fokus Mining: Best Drill Results to Date

"We are very pleased with these results, which suggest that the RB zone may extend to the surface. Although further drilling is required to confirm this hypothesis, this possibility is very promising. This would be even more interesting as it would open up other prospects for the GP Zone adjacent to the RB Zone," said Jean Rainville, President and CEO. ...read more

RE:RE:Q3 EPS: Pipeline Remains on Track

https://www.cocrystalpharma.com/news/press-releases/detail/115/cocrystal-pharma-reports-2020-financial-results-provides  rate and reply

RE:Q3 EPS: Pipeline Remains on Track

https://www.cocrystalpharma.com/news/press-releases/detail/114/cocrystal-pharma-extends-drug-discovery-collaboration-with  rate and reply

Q3 EPS: Pipeline Remains on Track

Q3 EPS: Pipeline Remains on Track https://www.channelchek.com/news-channel/Cocrystal_Pharma_Inc.__COCP____Q3_EPS_Pipeline_Remains_on_Track  rate and reply

Cocrystal Pharma Provides Update on Influenza A Program

BOTHELL, WA, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), announces promising in vitro and 7-day toxicity data for its influenza A...read more

The Timing of a COVID Vaccine

A little tiff between the FDA and Trump  https://www.channelchek.com/news-channel/The_Timing_of_a_COVID_Vaccine    rate and reply

Strategic decision to discontinue development of pimodivir

The Janssen Pharmaceutical announced a strategic decision to discontinue the development of pimodivir, a Phase 3 clinical asset.  What does it mean? More at: https://www.channelchek.com...read more